StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Fidelity 22 and Penson 5

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Sep 09, 2021 3:23pm

134 Views

Post# 33834728

RE:Fidelity 22 and Penson 5

Another very strange situation is that the TSX is less than half the overall volume. This has been happening more and more of late.

So far today 84,400 in volume and TSX is only 37,700 of that (45%)

It's just more quiet accumulation by certain houses on certain exchanges.

Photoman77 wrote: Fidelity 22 and Penson 5 seem to be buying together today. Not sure if this has been a trend but it seems to be the same buyer buying through two accounts at the same time.

<< Previous

Bullboard Posts

Next >>

This junior mining stock offers billions in market exposure